SCOPUS 정보 검색 플랫폼

Annals of Hematology

Volumn 86, Issue 7, 2007, Pages 537-538

Imatinib-induced Stevens-Johnson syndrome: Recurrence after re-challenge with a lower dose [4]

(3) Mahapatra, Manoranjan a Mishra, Pravas a Kumar, Rajat a

a ALL INDIA INSTITUTE OF MEDICAL SCIENCES (India)

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; HYDROXYUREA; IMATINIB; PREDNISOLONE;

ACANTHOSIS; ADULT; BLOOD ANALYSIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LOW DRUG DOSE; MACULOPAPULAR RASH; MALE; PARAKERATOSIS; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; RETREATMENT; SKIN BIOPSY; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; TREATMENT DURATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RECURRENCE; STEVENS-JOHNSON SYNDROME;

EID: 34249914496 PISSN: 09395555 EISSN: None Source Type: Journal
DOI: 10.1007/s00277-007-0265-y Document Type: Letter

Times cited : (24)

References (7)

1
- 0344556916
- Adverse reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients
- Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P et al (2003) Adverse reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients. J Am Acad Dermatol 48:201-206
- (2003) J Am Acad Dermatol , vol.48 , pp. 201-206
- Valeyrie, L.¹ Bastuji-Garin, S.² Revuz, J.³ Bachot, N.⁴ Wechsler, J.⁵ Berthaud, P.⁶

2
- 0035939714
- Cutaneous reactions to STI571
- Brouard M, Saurat JH (2001) Cutaneous reactions to STI571. N Engl J Med 345:618-619
- (2001) N Engl J Med , vol.345 , pp. 618-619
- Brouard, M.¹ Saurat, J.H.²

3
- 23944519724
- Imatinib induced Stevens-Johnson syndrome: Lack of recurrence following re-challenge with a lower dose
- Keechilat P, Mathew T (2005) Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose. Indian J Dermatol Venereol Leprol 71(4):288-289
- (2005) Indian J Dermatol Venereol Leprol , vol.71 , Issue.4 , pp. 288-289
- Keechilat, P.¹ Mathew, T.²

4
- 0036400328
- STI571-induced Stevens-Johnson syndrome
- Vidal D, Puig L, Sureda A, Alomar A (2002) STI571-induced Stevens-Johnson syndrome. Br J Haematol 119:274-275
- (2002) Br J Haematol , vol.119 , pp. 274-275
- Vidal, D.¹ Puig, L.² Sureda, A.³ Alomar, A.⁴

5
- 0036110317
- Stevens-Johnson syndrome after treatment with STI571: A case report
- Hsiao LT, Chung HM, Lin JT, Chiou TJ, Liu JH, Fan FS et al (2002) Stevens-Johnson syndrome after treatment with STI571: A case report. Br J Haematol 117:620-622
- (2002) Br J Haematol , vol.117 , pp. 620-622
- Hsiao, L.T.¹ Chung, H.M.² Lin, J.T.³ Chiou, T.J.⁴ Liu, J.H.⁵ Fan, F.S.⁶

6
- 0036839001
- Managing cutaneous reactions to imatinib therapy
- Rule SA, O'Brien SG, Crossman LC (2002) Managing cutaneous reactions to imatinib therapy. Blood 100:3434-3435
- (2002) Blood , vol.100 , pp. 3434-3435
- Rule, S.A.¹ O'Brien, S.G.² Crossman, L.C.³

7
- 34249891492
- Dasatanib vs escalated dose of imatinib in patients with chronic phase chronic myeloid leukemia resistant to imatinib: Results of the CA180-017 START-R randomized study
- Shah N, Pasquini R, Rousselet P, Jootar S, Holowiecki J, Countouriotis A, Dejardin D, Hughes T, Druker BJ (2006) Dasatanib vs escalated dose of imatinib in patients with chronic phase chronic myeloid leukemia resistant to imatinib: Results of the CA180-017 START-R randomized study. Blood 108:167a
- (2006) Blood , vol.108
- Shah, N.¹ Pasquini, R.² Rousselet, P.³ Jootar, S.⁴ Holowiecki, J.⁵ Countouriotis, A.⁶ Dejardin, D.⁷ Hughes, T.⁸ Druker, B.J.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.